Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Advanced glycation in uraemic toxicity.

C van Ypersele de Strihou¹

¹University of Louvain Medical School, Cliniques Universitaires St. Luc, Brussels, Belgium.

EDTNA/ERCA Journal (English Ed.)

|October 14, 2003

Summary

The Maillard reaction produces advanced glycation end products (AGEs) and reactive carbonyl compounds (RCOs), accelerating uraemic toxicity in diabetes and renal failure. Reducing AGEs and RCOs via dialysis or drugs may mitigate toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Clinical Practice of Nephrology.

Acta clinica Belgica·2016

Same author

Thiazolidinediones provide better renoprotection than insulin in an obese, hypertensive type II diabetic rat model.

Kidney international·2007

Same author

Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient.

Kidney international·2001

Same author

Aristolochic acid nephropathy in a Chinese patient: time to abandon the term "Chinese herbs nephropathy"?

American journal of kidney diseases : the official journal of the National Kidney Foundation·2001

Same author

Morphogenesis of joint beta 2-microglobulin amyloid deposits.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2001

Same author

Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2001

Area of Science:

Biochemistry
Nephrology
Gerontology

Background:

The Maillard reaction, a non-enzymatic process, forms advanced glycation end products (AGEs) from carbohydrates and proteins.
This reaction accelerates in diabetes (hyperglycemia) and renal failure (reactive carbonyl compound accumulation), contributing to uraemic toxicity.
AGEs and reactive carbonyl compounds (RCOs) are linked to clinical issues like dialysis amyloidosis, atherosclerosis, and altered peritoneal membrane permeability.

Purpose of the Study:

To explore the role of AGEs and RCOs in uraemic toxicity.
To identify therapeutic strategies for reducing AGEs and RCOs to mitigate uraemic toxicity.

Main Methods:

Review of biochemical and clinical implications of AGEs and RCOs in uraemia.
Analysis of therapeutic interventions including dialysis techniques and pharmacological agents.

Main Results:

AGEs and RCOs are biochemical and clinical contributors to uraemic toxicity.
Therapeutic strategies targeting AGEs and RCOs show promise in reducing uraemic toxicity.

Conclusions:

Reducing plasma AGEs and RCOs is a potential therapeutic target for uraemic toxicity.
Dialysis modifications and drugs inhibiting AGE formation are viable strategies to reduce uraemic toxicity.

Related Experiment Videos